Impact Biomedical IBO
NYSE IBO
$3.80 -0.31 (-7.54%)
At close: Oct 22, 2026 · 4:00 PM EDT

Impact Biomedical (IBO) Receivables - Net (2024 - 2025)

Updated

Impact Biomedical (IBO) reported Receivables - Net of $5,000 for Q4 2025, down 97.5% from $201,000 a year earlier and down 97.5% from the prior quarter.

Analysis

Impact Biomedical (IBO) Receivables - Net (2024 - 2025) Analysis & Trends

Dating back to Q1 2024, Impact Biomedical's Receivables - Net record includes 7 quarters.

  • By year, Receivables - Net came in at $201,000 in FY2024.
  • Per Business Quant data, the three quarters before Q4 2025 came in at $199,000 (Q3 2025), $200,000 (Q2 2025) and $200,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Impact Biomedical 409.72 Mn 412.92 Mn 2,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 5,000.00
Sep 30, 2025 199,000.00
Jun 30, 2025 200,000.00
Mar 31, 2025 200,000.00
Dec 31, 2024 201,000.00
Jun 30, 2024 128,000.00
Mar 31, 2024 128,000.00
API Access

Impact Biomedical Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=IBO&period=max&api_key=YOUR_API_KEY